Vermont monitors marketing to physicians

A new law going into effect on July 1 in Vermont will make drug and device makers disclose the amount of money given to all physicians and healthcare providers. The laws will be the most stringent imposed by a state. This will in effect allow all citizens of the state to view what the doctors are paid by the drug makers.

In practice, the new law would let Vermonters learn each year which doctors have been paid, and how much, by the makers of the brand-name drugs for which they wrote prescriptions — or how much money certain surgeons have received from the makers of the stents, pacemakers, artificial knees and such that the doctors implanted.

Read the full article here.

If you're interested in networking with other professionals who market to physicians, join us in these groups:
Join MDRX on LinkedIn: http://www.linkedin.com/groups?gid=1811679
Follow MDRX on Twitter: http://twitter.com/mktg2docs

Share this article with your social network, just click below to share now!

Share |

Word of mouth marketing and Pharma

In a recent article at CNN, they explain the findings of marketers who set out to find out how word of mouth marketing travels for prescription drugs. It's anyone's dream for their product to pick up a buzz that travels and promotes a product. This particular study, done by marketing professors at University of Pennsylvania's business school set out ot find out who the "connectors," or those spreading the news about the new drug throughout social circles, for particular drugs. They started by finding physicians and what social networks they were a part of. In this particular study, they found that the proponent was a doctor with lots of connections that bridged two networks. He was well respected, but not outspoken.

The study found that so-called "sociometric" leaders like Physician 184 had more of an influence on word-of-mouth buzz than the self-reported opinion leaders, perhaps because the latter group tend to be less involved with their peers.

Read the complete story here.

We'd like to hear your thoughts on physician and Pharma marketing throughout Pharma on our Future of BioPharma LinkedIn group and MDRx LinkedIn group. Join us today!

Share this article with your social network, just click below to share now!

Share |